FDA Inspection
JEAN BERGERONJEAN BERGERON – FDA Inspection, Dec 12, 2025
Record Details
This FDA Inspection record concerns JEAN BERGERON, with an inspection on December 12, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 7df1be56-e810-4efa-a1f3-9ed36bbc941a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1296524
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 50.25(a)(6)Compensation, medical treatment in event of injury
- 21 CFR 50.25(a)(7)Whom to contact
- 21 CFR 50.25(b)(3)Possible additional costs to the subject
Full citation text and observation details available on the Dashboard.
Other FDA inspections of JEAN BERGERON
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 3, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 26, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for JEAN BERGERON
- FDA Inspection 1215415 - 2023-08-03
- FDA Inspection 1043450 - 2018-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.